Audience
Medical institutions seeking a solution to enhance the detection of dysplasia in Barrett’s oesophagus during gastroscopy procedures
About CADU
CADU is a cloud-based AI system developed by Odin Vision to assist in the detection and characterization of dysplasia in patients with Barrett’s oesophagus during gastroscopy procedures. It analyzes regions visually consistent with Barrett’s oesophagus and provides information to aid the user in identifying the tissue as dysplastic or non-dysplastic. CADU enhances endoscopists' decision-making and reduces the time it takes to inspect the oesophagus, proving to be time and cost-effective. CADU operates on a vendor-neutral platform, ensuring compatibility with existing endoscopy equipment. It is CE marked and UKCA approved, though it is not available for sale in the United States. CADU has been implemented in clinical settings, such as University College London Hospitals, to improve the detection of early-stage oesophageal cancer, a condition often challenging to diagnose due to the subtlety of early lesions.